<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Denali Therapeutics Inc. (DNLI) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/dnli/</link>
<description>Every dated entry in the public record on Denali Therapeutics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/dnli/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Wed, 28 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Denali Therapeutics Inc.: short interest 15,475,322 shares at the 15 October 2026 settlement, 8.07 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-10-15:2886e05eee</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: short interest 15,463,975 shares at the 30 September 2026 settlement, 7.64 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-09-30:0f176952b4</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: short interest 17,139,415 shares at the 15 September 2026 settlement, 11.97 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-09-15:ed01f72413</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Chin Peter Scott (Chief Medical Officer) sold 1,654 shares at $22.29 on 4 September 2026, $36,868</title><link>https://greeksoup.ai/stocks/us/dnli/insiders/</link><guid isPermaLink="false">us:DNLI:insider:2026-09-09:9f3298c184</guid><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000212475526000007/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Form 144, Chin Peter Scott plans to sell 1,654 shares worth $36,867 around 4 September 2026</title><link>https://greeksoup.ai/stocks/us/dnli/planned-sales/</link><guid isPermaLink="false">us:DNLI:planned-sale:2026-09-04:14000f44eb</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000212475526000006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Thornberry Nancy (Director) sold 10,824 shares (under a trading plan set in advance) at $22.85 on 2 September 2026, $247,328</title><link>https://greeksoup.ai/stocks/us/dnli/insiders/</link><guid isPermaLink="false">us:DNLI:insider:2026-09-04:0d005fba2d</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000179782626000006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Thornberry Nancy (Director) sold 615 shares (under a trading plan set in advance) at $23.74 on 2 September 2026, $14,600</title><link>https://greeksoup.ai/stocks/us/dnli/insiders/</link><guid isPermaLink="false">us:DNLI:insider:2026-09-04:0400095fcd</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000179782626000006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Schuth Alexander O. (COFO and Secretary) sold 2,768 shares (under a trading plan set in advance) at $23.44 on 1 September 2026, $64,882</title><link>https://greeksoup.ai/stocks/us/dnli/insiders/</link><guid isPermaLink="false">us:DNLI:insider:2026-09-03:9363016e14</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000172431126000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Form 144, NANCY THORNBERRY plans to sell 11,439 shares worth $266,128 around 2 September 2026</title><link>https://greeksoup.ai/stocks/us/dnli/planned-sales/</link><guid isPermaLink="false">us:DNLI:planned-sale:2026-09-02:4c6268c618</guid><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000195004726009017/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Form 144, ALEXANDER SCHUTH plans to sell 2,768 shares worth $65,768 around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/dnli/planned-sales/</link><guid isPermaLink="false">us:DNLI:planned-sale:2026-09-01:a193ee1c15</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000195004726008944/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: short interest 16,642,362 shares at the 31 August 2026 settlement, 17.50 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-08-31:8d7b190e86</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: short interest 17,959,465 shares at the 14 August 2026 settlement, 12.41 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-08-14:56cba60968</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Schuth Alexander O. (COFO and Secretary) sold 2,857 shares at $25.07 on 11 August 2026, $71,625</title><link>https://greeksoup.ai/stocks/us/dnli/insiders/</link><guid isPermaLink="false">us:DNLI:insider:2026-08-13:c874a0fcd4</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000172431126000013/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Form 144, Schuth Alexander O. plans to sell 2,857 shares worth $71,624 around 11 August 2026</title><link>https://greeksoup.ai/stocks/us/dnli/planned-sales/</link><guid isPermaLink="false">us:DNLI:planned-sale:2026-08-11:efe654b334</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000172431126000012/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc. Q2 FY2025 results: revenue $0, net income -$124 million</title><link>https://greeksoup.ai/stocks/us/dnli/results/fy2025-q2/</link><guid isPermaLink="false">us:DNLI:result:2026-08-06:8867a4db9c</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001714899&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/results/fy2025-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc. Q2 FY2026 results: revenue $4 million, net income -$128 million</title><link>https://greeksoup.ai/stocks/us/dnli/results/fy2026-q2/</link><guid isPermaLink="false">us:DNLI:result:2026-08-06:0dde898463</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001714899&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/dnli/filings/</link><guid isPermaLink="false">us:DNLI:filing:2026-08-06:b18804d4ef</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000171489926000097/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/dnli/filings/</link><guid isPermaLink="false">us:DNLI:filing:2026-08-06:773cc80972</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000171489926000096/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: Schedule 13G/A filed by BAILLIE GIFFORD &amp; CO, 7.5% of the class</title><link>https://greeksoup.ai/stocks/us/dnli/holders/</link><guid isPermaLink="false">us:DNLI:schedule-13:2026-08-04:033fe325af</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1714899/000108887526000056/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Denali Therapeutics Inc.: short interest 17,434,654 shares at the 31 July 2026 settlement, 12.12 days to cover</title><link>https://greeksoup.ai/stocks/us/dnli/short-interest/</link><guid isPermaLink="false">us:DNLI:short-interest:2026-07-31:85fbb41448</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/dnli/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
